Condition: Biliary Tract Adenocarcinoma
Intervention:
Sponsors: Far Eastern Memorial Hospital; Far Eastern Memorial Hospital
Active, not recruiting - verified December 2010
Feeds
4580 items (4580 unread) in 80 feeds
Acinar Cell Carcinoma
(28 unread)
Acinic Cell Carcinoma
(32 unread)
Adenoid Cystic Carcinoma
(56 unread)
Adrenal Gland Cancer
(327 unread)
Ampulla Of Vater
(14 unread)
Anal Cancer
(252 unread)
Angiosarcoma
(72 unread)
Appendix Cancer
(34 unread)
Bile Duct Cancer
(385 unread)
Brain and CNS
(1133 unread)
Carcinoid
(143 unread)
Endocrine/Neuroendocrine
(291 unread)
Gall Bladder Cancer
(223 unread)
Hemangioendothelioma
(23 unread)
Hepatoblastoma
(30 unread)
Pancreas
(45 unread)
Phyllodes
(21 unread)
PMP and Mucinous Tumors
(19 unread)
Rhabdomyosarcoma
(186 unread)
Sarcoma
(600 unread)
Twitter Pals
(666 unread)
Trial - Cholangiocarcinoma (12 unread)
-
Mutation Analysis and Copy Number Changes of KRAS and BRAF Gene in Taiwanese Cases of Biliary Tact Adenocarcinoma
Posted: April 27th, 2012, 8:00am MDT
-
ERCP-based Sampling of Indeterminate Bile Duct Strictures
Posted: April 17th, 2012, 8:00am MDT
Condition: Indeterminate Bile Duct Stricture
Interventions: Procedure: Multiple brushings; Procedure: Multimodality tissue sampling
Sponsors: Indiana University; Indiana University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified April 2012 -
The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous Cytokine-induced Killer Cells
Posted: April 5th, 2012, 8:00am MDT
Condition: Cholangiocarcinoma
Intervention: Drug: cytokine induced killer cells
Sponsors: Siriraj Hospital; Siriraj Hospital; Mahidol University
Recruiting - verified April 2012 -
Study of Hepatic Arterial Infusion to Treat Hilar Cholangiocarcinoma
Posted: April 4th, 2012, 8:00am MDT
Condition: Cholangiocarcinoma
Intervention: Drug: Oxaliplatin, Fluorouracil, Leucovorin, Capecitabine
Sponsors: Peking University; Peking University
Recruiting - verified April 2012 -
Clinical Relevance of ROS (V-ros UR2 Sarcoma Virus Oncogene Homolog) Aberrations in Solid Tumours
Posted: April 2nd, 2012, 8:00am MDT
Condition: Cancer
Intervention:
Sponsors: National University Hospital, Singapore; National University Hospital, Singapore
Recruiting - verified April 2012 -
BKM120 in Cancers With PIK3CA Activating Mutations
Posted: December 27th, 2011, 8:00am MST
Conditions: Lung Cancer; Breast Cancer; Colorectal Cancer; Cholangiocarcinoma; Solid Tumors
Intervention: Drug: BKM120
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Novartis Pharmaceuticals
Recruiting - verified April 2012 -
Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
Posted: September 20th, 2010, 8:00am MDT
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine; Drug: Oxaliplatin; Drug: Capecitabine; Drug: Panitumumab; Drug: Bevacizumab
Sponsors: Vejle Hospital; Vejle Hospital
Recruiting - verified May 2012 -
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
Posted: March 24th, 2010, 8:00am MDT
Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer
Interventions: Drug: erlotinib hydrochloride; Drug: sorafenib tosylate
Sponsors: National Cancer Institute (NCI); Southwest Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified September 2011 -
A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
Posted: January 5th, 2010, 8:00am MST
Condition: Cholangiocarcinoma
Intervention: Drug: Gemcitabine
Sponsors: National Cancer Center, Korea; National Cancer Center, Korea; Dong-A Pharmaceutical Co., Ltd.
Recruiting - verified April 2012 -
Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
Posted: October 22nd, 2008, 8:00am MDT
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine, Oxaliplatin, Capecitabine,; Drug: Panitumumab, Gemcitabine, Oxaliplatin, Capecitabine
Sponsors: Vejle Hospital; Vejle Hospital
Recruiting - verified May 2012 -
Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases
Posted: April 23rd, 2007, 8:00am MDT
Conditions: Hepatocellular Cancer; Cholangiocarcinoma; Hepatic Metastases
Intervention: Procedure: Proton Beam Radiation
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Cancer Institute (NCI); Dana-Farber Cancer Institute; Brigham and Women's Hospital
Active, not recruiting - verified May 2012 -
DX-8951f in Treating Patients With Biliary Cancer
Posted: July 5th, 2000, 8:00am MDT
Conditions: Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer
Intervention: Drug: exatecan mesylate
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Completed - verified May 2012